Avinash Kumar

Pterostilbene, a natural phenolic compound, synergizes the antineoplastic effects of megestrol acetate in endometrial cancer

Flavonoids as natural phenolic compounds and their role in therapeutics: an overview

Plant flavonoids: Classification, distribution, biosynthesis, and antioxidant activity

Phytochemicals in Cancer Treatment: From Preclinical Studies to Clinical Practice

The STRING database in 2017: quality-controlled protein–protein association networks, made broadly accessible

Inflammation and tumor progression: signaling pathways and targeted intervention

Measuring the multifaceted roles of mucin-domain glycoproteins in cancer

The JAK/STAT signaling pathway: from bench to clinic

Piceatannol: A natural stilbene for the prevention and treatment of cancer

Resveratrol as an anti-cancer agent: A review

Natural Polyphenols for Prevention and Treatment of Cancer

A detailed image of rutin underlying intracellular signaling pathways in human SW480 colorectal cancer cells based on miRNAs‐lncRNAs‐mRNAs‐TFs interactions

Traditional Chinese medicine as a cancer treatment: Modern perspectives of ancient but advanced science

Comprehensive comparison of large-scale tissue expression datasets

The Role of Polyphenols in Abiotic Stress Response: The Influence of Molecular Structure

Prognostic Value of MUC2 Expression in Colorectal Cancer: A Systematic Review and Meta-Analysis

Unraveling the Anticancer Effect of Curcumin and Resveratrol

Bioactive Compounds and Biological Functions of Garlic (Allium sativum L.)

Plant Secondary Metabolites as Anticancer Agents: Successes in Clinical Trials and Therapeutic Application

Therapeutic Versatility of Resveratrol Derivatives

Resveratrol and pterostilbene: A comparative overview of their chemistry, biosynthesis, plant sources and pharmacological properties

Molecular insight into the differential anti-androgenic activity of resveratrol and its natural analogs: in silico approach to understand biological actions

Resveratrol regulates PTEN/Akt pathway through inhibition of MTA1/HDAC unit of the NuRD complex in prostate cancer

Targeting MTA1/HIF‐1α signaling by pterostilbene in combination with histone deacetylase inhibitor attenuates prostate cancer progression

Resveratrol and pterostilbene as a microRNA‐mediated chemopreventive and therapeutic strategy in prostate cancer

Resveratrol and pterostilbene epigenetically restore PTEN expression by targeting oncomiRs of the miR-17 family in prostate cancer

Epigenetic potential of resveratrol and analogs in preclinical models of prostate cancer

Mass Spectrometry-Based Proteomics in Molecular Diagnostics: Discovery of Cancer Biomarkers Using Tissue Culture

Dietary pterostilbene is a novel MTA1-targeted chemopreventive and therapeutic agent in prostate cancer